Drug Royalty III LP 1’s Senior Secured Notes Offering
December 20, 2018
Cravath represented Drug Royalty III LP 1 in connection with its $100 million Rule 144A senior secured notes offering. Drug Royalty III LP 1 is a special purpose limited partnership that owns assets related to pharmaceutical products. The transaction closed on December 7, 2018.
The Cravath team included partner Nicholas A. Dorsey, senior attorney Elizabeth Albert and associates Randall F. Limberg and Samuel A. Lifton on securities matters; partner David J. Kappos, practice area attorney Anthony N. Magistrale and associate Joel Feigenbaum on intellectual property matters; and associate Arvind Ravichandran on tax matters. Seann E. Archibald also worked on securities matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2009, Cornell Law SchoolOrder of the Coif, summa cum laude
-
M.Acc., 2006, Case Western Reserve Universitysumma cum laude
-
B.S., 2006, Case Western Reserve Universitysumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1987, Yale Law Schoolwith Honors
-
A.B., 1984, Harvard Collegecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
December 24, 2025
Acushnet Company’s High‑Yield Senior Notes Offering
Cravath represented the initial purchasers in connection with the $500 million 144A/Reg. S high‑yield senior notes offering of Acushnet Company, a wholly‑owned subsidiary of Acushnet Holdings Corp., a global leader in the design, development, manufacture and distribution of performance‑driven golf products. The transaction closed on November 24, 2025.
Deals & Cases
December 17, 2025
Smurfit Westrock’s Registered Senior Notes Offerings
Cravath represented the underwriters in connection with the $800 million registered senior notes offering of Smurfit Westrock Financing DAC and the €500 million registered senior notes offering of Smurfit Kappa Treasury Unlimited Company, each a wholly owned subsidiary of Smurfit Westrock plc, one of the world's largest integrated manufacturers of paper‑based packaging products. The notes are expected to be listed on Euronext Dublin. The transactions closed on November 21, 2025, and November 24, 2025, respectively.
Deals & Cases
December 16, 2025
Graham Holdings Company’s Senior Notes Offering
Cravath represented Graham Holdings Company in connection with its $500 million 144A/Reg. S senior notes offering. Graham Holdings Company is a diversified holding company whose operations include educational services, television broadcasting, manufacturing, healthcare, automotive dealerships and other businesses. The transaction closed on November 24, 2025.
Deals & Cases
December 15, 2025
Enerflex Inc.’s High‑Yield Senior Notes Offering
Cravath represented Enerflex Inc. in connection with its $400 million 144A/Reg. S high‑yield senior notes offering. Enerflex is a premier integrated global provider of energy infrastructure and energy transition solutions, deploying natural gas, low‑carbon and treated water solutions – from individual, modularized products and services to integrated custom solutions. The transaction closed on December 11, 2025.
